Search results
Chief Scientific Officer, Memorial Sloan Kettering Cancer Center; Director, Sloan Kettering Institute; Marie-Josée and Henry R. Kravis Chair; Member, Cancer Biology & Genetics Program. Joan Massagué studies the control of stem cell growth and phenotype in tumor progression, metastasis, and response to therapy. PhD, University of Barcelona.
- Research Overview
Joan Massagué: Research Overview. We are interested in...
- View All Open Positions
The Joan Massagué Lab: Open Positions. Share. Share. The...
- Research Technician, Sr
View the Joan Massagué Lab page for Research Technician,...
- Post Doctoral Position
The Massague lab is seeking candidates with experience in...
- Featured News
Joan Massagué, Chair of the Cancer Biology and Genetics...
- Publications
Morgani SM, Su J, Nichols J, Massagué J, Hadjantonakis AK....
- Research Overview
Joan Massagué (born April 30, 1953), is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell ...
Joan Massagué, PhD, a world leader in research on signaling pathways and transcriptional programs that regulate normal cell behavior and cancer metastasis. He is the Chief Scientific Officer of Memorial Sloan Kettering and Director of the Sloan Kettering Institute.
Joan Massague. Memorial Sloan Kettering Cancer Cencer. Verified email at mskcc.org - Homepage. ... PM Siegel, J Massagué. Nature Reviews Cancer 3 (11), 807-820, 2003 ...
Dec 12, 2023 · Joan Massagué, 70, says that a great change is taking place in science’s ongoing battle against cancer. New research into metastasis has led to a leap of knowledge that is so great it is...
Joan Massague. Professor. Phone: 646-888-2044. Email: massaguj@mskcc.org. Lab Website. We are interested in metastasis, the cause of 90% cancer deaths. The lab investigates metastatic stem cells and their stromal niches. The role of immune regulatory and regenerative signals, particularly TGF-β, is of interest.
